Drug profile · INN
pioglitazone hydrochloride
PIOGLITAZONE HYDROCHLORIDE
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
pioglitazone hydrochloride (PIOGLITAZONE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12385026
Stabilized alpha-galactosidase and uses thereof
granted -
US 12268700
3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof
granted -
US 12194079
Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase
granted -
US 11396571
Polymers including galactose based blocks and uses thereof
granted -
US 11116823
Treatment of α-galactosidase a deficiency
granted -
US 10870842
Stabilized alpha-galactosidase and uses thereof
granted -
US 10744154
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
granted -
US 10280414
Stabilized α-galactosidase and uses thereof
granted
Frequently asked questions
What is pioglitazone hydrochloride?
pioglitazone hydrochloride (PIOGLITAZONE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pioglitazone hydrochloride?
PIOGLITAZONE HYDROCHLORIDE is a marketed brand name for pioglitazone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pioglitazone hydrochloride?
pioglitazone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.